What does CUSIP 03969K108 represent in this 13F holders report?

CUSIP 03969K108 is the security identifier for ARQT - Arcutis Biotherapeutics, Inc. - Common used to aggregate holder disclosures.

How many institutions held ARQT - Arcutis Biotherapeutics, Inc. - Common in Q4 2021?

89 institutional investors reported ARQT - Arcutis Biotherapeutics, Inc. - Common for Q4 2021. Use the holders table for investor-level position and value details.

Arcutis Biotherapeutics, Inc. - Common (ARQT)

CUSIP: 03969K108

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common
Shares outstanding: 123,318,907
Total 13F shares: 46,348,278
Share change: +33,258
Total reported value: $961,255,152
Put/Call ratio: 22%
Price per share: $20.74
Number of holders: 89
Value change: -$1,852,441
Number of buys: 47
Number of sells: 40

Quarterly Holders Quick Answers

What is CUSIP 03969K108?
CUSIP 03969K108 identifies ARQT - Arcutis Biotherapeutics, Inc. - Common in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 03969K108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ARQT - Arcutis Biotherapeutics, Inc. - Common (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FRAZIER MANAGEMENT LLC	13F	Company	6.8%	8,434,232	$201,494,000	—	30 Sep 2021	13F
FMR LLC	13F	Company	6.1%	7,536,265	$180,041,000	—	30 Sep 2021	13F
ORBIMED ADVISORS LLC	13F	Company	4.9%	6,073,850	$145,104,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	3.4%	4,195,926	$100,241,000	—	30 Sep 2021	13F
Bain Capital Life Sciences Investors, LLC	13F	Company	3.2%	3,979,292	$95,065,000	—	30 Sep 2021	13F
Point72 Asset Management, L.P.	13F	Company	1.6%	1,992,107	$47,591,000	—	30 Sep 2021	13F
Polar Capital Holdings Plc	13F	Company	1.3%	1,548,901	$37,003,000	—	30 Sep 2021	13F
VANGUARD GROUP INC	13F	Company	1.2%	1,492,207	$35,648,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	0.84%	1,039,213	$24,827,000	—	30 Sep 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.66%	813,694	$19,439,000	—	30 Sep 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.63%	773,214	$18,472,000	—	30 Sep 2021	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.62%	758,763	$18,127,000	—	30 Sep 2021	13F
Omega Fund Management, LLC	13F	Company	0.51%	623,836	$14,903,000	—	30 Sep 2021	13F
FRANKLIN RESOURCES INC	13F	Company	0.47%	575,208	$13,741,000	—	30 Sep 2021	13F
Pivotal bioVenture Partners Investment Advisor LLC	13F	Company	0.46%	569,041	$13,594,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.4%	488,855	$11,678,000	—	30 Sep 2021	13F
Vivo Capital, LLC	13F	Company	0.35%	433,585	$10,358,000	—	30 Sep 2021	13F
Ensign Peak Advisors, Inc	13F	Company	0.32%	389,938	$9,316,000	—	30 Sep 2021	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.3%	376,074	$8,985,000	—	30 Sep 2021	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.29%	362,035	$8,655,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	0.22%	270,519	$6,463,000	—	30 Sep 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.22%	265,932	$6,353,000	—	30 Sep 2021	13F
AXA S.A.	13F	Company	0.21%	259,084	$6,190,000	—	30 Sep 2021	13F
Altium Capital Management LLC	13F	Company	0.21%	255,000	$6,092,000	—	30 Sep 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.18%	219,392	$4,973,000	—	30 Sep 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.16%	195,837	$4,679,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	0.12%	143,731	$3,434,000	—	30 Sep 2021	13F
Tekla Capital Management LLC	13F	Company	0.11%	131,633	$3,145,000	—	30 Sep 2021	13F
Neuberger Berman Group LLC	13F	Company	0.1%	122,087	$2,916,000	—	30 Sep 2021	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.09%	112,324	$2,683,000	—	30 Sep 2021	13F
Bank of New York Mellon Corp	13F	Company	0.08%	95,064	$2,271,000	—	30 Sep 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.06%	79,395	$1,894,000	—	30 Sep 2021	13F
ALPS ADVISORS INC	13F	Company	0.05%	61,578	$1,471,000	—	30 Sep 2021	13F
NORGES BANK	13F	Company	0.05%	61,116	$1,460,000	—	30 Sep 2021	13F
Swiss National Bank	13F	Company	0.04%	55,200	$1,319,000	—	30 Sep 2021	13F
HAMILTON LANE ADVISORS LLC	13F	Company	0.04%	52,347	$1,251,000	—	30 Sep 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.03%	40,627	$971,000	—	30 Sep 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.03%	35,584	$850,000	—	30 Sep 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	35,513	$848,000	—	30 Sep 2021	13F
AlphaCentric Advisors LLC	13F	Company	0.03%	35,500	$848,000	—	30 Sep 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.02%	30,618	$731,000	—	30 Sep 2021	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.02%	30,596	$731,000	—	30 Sep 2021	13F
TD ASSET MANAGEMENT INC	13F	Company	0.02%	30,510	$729,000	—	30 Sep 2021	13F
Rafferty Asset Management, LLC	13F	Company	0.02%	30,223	$722,000	—	30 Sep 2021	13F
UBS Group AG	13F	Company	0.02%	30,155	$720,000	—	30 Sep 2021	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.02%	29,972	$716,031	—	30 Sep 2021	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.02%	27,970	$668,000	—	30 Sep 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.02%	27,700	$662,000	—	30 Sep 2021	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.02%	25,300	$604,000	—	30 Sep 2021	13F
CITIGROUP INC	13F	Company	0.02%	24,936	$596,000	—	30 Sep 2021	13F

Institutional Holders of Arcutis Biotherapeutics, Inc. - Common (ARQT) as of Q4 2021

As of 31 Dec 2021, Arcutis Biotherapeutics, Inc. - Common (ARQT) was held by 89 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,348,278 shares. The largest 10 holders included FRAZIER MANAGEMENT LLC, FMR LLC, ORBIMED ADVISORS LLC, BlackRock Inc., Bain Capital Life Sciences Investors, LLC, Point72 Asset Management, L.P., Polar Capital Holdings Plc, VANGUARD GROUP INC, STATE STREET CORP, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 89 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

103

Q4 2021 holders

Holder diff

-14

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.